Latest Period
Q1 2026
Security Snapshot
Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) Institutional Ownership
CUSIP: 09075F404
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
30
Shares (Excl. Options)
870,671
Price
$1.17
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- BNGO on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 870,671
- Total 13F value
- $1,018,155
- Portfolio coverage rank
- 0%
- Share change
- -52,033
- Value change
- -$153,994
- Number of holders
- 30
- Shares outstanding
- 11,229,947
- SEC-reported price per share
- $1.25
- Insider filing price
- $1.25
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 09075F404.
- 30 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 30 to 30 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,354,479 to $1,018,155.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 30 institutions filings for Q1 2026.
Security key
09075F404
Latest holder period
Q1 2026
13F holders
30
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
BNGO full holder history
Bionano Genomics, Inc. SEC filings
Bionano Genomics, Inc. company facts
Bionano Genomics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09075F404:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BNGO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $1,795,763 | +$171,307 | 1,129,411 | +11% | CVI Investments, Inc. | 31 Dec 2025 |
| Lind Global Fund III LP | 9.4% | -5.5% | $1,669,500 | +$851,703 | 1,050,000 | +104% | Lind Global Fund III LP | 31 Dec 2025 |
| Ayrton Capital LLC | 10% | $903,140 | 528,245 | Ayrton Capital LLC | 30 Sep 2025 | |||
| Lincoln Alternative Strategies LLC | 5.4% | $2,021,250 | 525,000 | Lincoln Alternative Strategies LLC | 17 Sep 2025 | |||
| Iroquois Capital Management, LLC | 5% | -8.2% | $871,362 | -$26,230 | 509,658 | -2.9% | Iroquois Capital Management, LLC | 30 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,957,398 | 508,415 | Mitchell P. Kopin | 16 Sep 2025 |
As of 31 Mar 2026, 30 institutional investors reported holding 870,671 shares of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO). This represents 7.8% of the company’s total 11,229,947 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q1 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 870,671 | $1,018,155 | -$153,994 | $1.17 | 30 |
| 2025 Q4 | 885,151 | $1,354,479 | +$972,920 | $1.53 | 30 |
| 2025 Q3 | 244,406 | $417,230 | +$180,899 | $1.71 | 29 |
| 2025 Q2 | 100,433 | $328,973 | +$12,075 | $3.28 | 25 |
| 2025 Q1 | 104,118 | $290,503 | +$210,076 | $2.79 | 27 |
| 2024 Q4 | 198,732 | $57,021 | +$54,382 | $0.29 | 5 |